Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil

Edward L. Schwartz, N. Baptiste, S. Wadler, Della F. Makower

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Interferon-α (IFNα) potentiates the antitumor activity of 5- fluorouracil (FUra) in colon cancer in vitro, in vivo, and clinically. A likely mechanism for this action is the induction by IFNα of thymidine phosphorylase (TP), the first enzyme in one pathway for the metabolic activation of FUra to fluorodeoxyribonucleotides. To test this hypothesis, an expression vector containing the TP cDNA was transfected into HT-29 human colon carcinoma cells. Five stable transfectants were selected and analyzed. All showed increased sensitivity to FUra cytotoxicity, ranging from a 2-fold to a 19-fold decrease in the IC50 for FUra, compared to wild-type cells. Levels of TP mRNA, protein, and enzyme activity were elevated in the transfectants, and there was a significant correlation between the relative increase in sensitivity to FUra and both the increase in both TP mRNA levels and TP activity. Transfected cells exhibited increased formation of FdUMP, but not the ribonucleotides FUDP and FUTP, from FUra when compared to wild- type cells. The changes in TP activity, FdUMP formation, and FUra sensitivity in the transfected cells were comparable with those seen after treatment of wild-type cells with IFNα. These studies provide direct evidence for the role of TP in mediating the sensitivity of colon carcinoma cells to FUra, and further support the importance of the induction of TP in the biomodulating action of IFNα on FUra chemosensitivity.

Original languageEnglish (US)
Pages (from-to)19073-19077
Number of pages5
JournalJournal of Biological Chemistry
Volume270
Issue number32
DOIs
StatePublished - 1995

Fingerprint

Thymidine Phosphorylase
Fluorouracil
Colon
Cells
Carcinoma
Interferons
Fluorodeoxyuridylate
Ribonucleotides
Messenger RNA
Enzyme activity
Enzymes
Cytotoxicity
Colonic Neoplasms
Inhibitory Concentration 50
Complementary DNA
Chemical activation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. / Schwartz, Edward L.; Baptiste, N.; Wadler, S.; Makower, Della F.

In: Journal of Biological Chemistry, Vol. 270, No. 32, 1995, p. 19073-19077.

Research output: Contribution to journalArticle

@article{17fb82f491d64be8b734e04565a386e3,
title = "Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil",
abstract = "Interferon-α (IFNα) potentiates the antitumor activity of 5- fluorouracil (FUra) in colon cancer in vitro, in vivo, and clinically. A likely mechanism for this action is the induction by IFNα of thymidine phosphorylase (TP), the first enzyme in one pathway for the metabolic activation of FUra to fluorodeoxyribonucleotides. To test this hypothesis, an expression vector containing the TP cDNA was transfected into HT-29 human colon carcinoma cells. Five stable transfectants were selected and analyzed. All showed increased sensitivity to FUra cytotoxicity, ranging from a 2-fold to a 19-fold decrease in the IC50 for FUra, compared to wild-type cells. Levels of TP mRNA, protein, and enzyme activity were elevated in the transfectants, and there was a significant correlation between the relative increase in sensitivity to FUra and both the increase in both TP mRNA levels and TP activity. Transfected cells exhibited increased formation of FdUMP, but not the ribonucleotides FUDP and FUTP, from FUra when compared to wild- type cells. The changes in TP activity, FdUMP formation, and FUra sensitivity in the transfected cells were comparable with those seen after treatment of wild-type cells with IFNα. These studies provide direct evidence for the role of TP in mediating the sensitivity of colon carcinoma cells to FUra, and further support the importance of the induction of TP in the biomodulating action of IFNα on FUra chemosensitivity.",
author = "Schwartz, {Edward L.} and N. Baptiste and S. Wadler and Makower, {Della F.}",
year = "1995",
doi = "10.1074/jbc.270.32.19073",
language = "English (US)",
volume = "270",
pages = "19073--19077",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "32",

}

TY - JOUR

T1 - Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil

AU - Schwartz, Edward L.

AU - Baptiste, N.

AU - Wadler, S.

AU - Makower, Della F.

PY - 1995

Y1 - 1995

N2 - Interferon-α (IFNα) potentiates the antitumor activity of 5- fluorouracil (FUra) in colon cancer in vitro, in vivo, and clinically. A likely mechanism for this action is the induction by IFNα of thymidine phosphorylase (TP), the first enzyme in one pathway for the metabolic activation of FUra to fluorodeoxyribonucleotides. To test this hypothesis, an expression vector containing the TP cDNA was transfected into HT-29 human colon carcinoma cells. Five stable transfectants were selected and analyzed. All showed increased sensitivity to FUra cytotoxicity, ranging from a 2-fold to a 19-fold decrease in the IC50 for FUra, compared to wild-type cells. Levels of TP mRNA, protein, and enzyme activity were elevated in the transfectants, and there was a significant correlation between the relative increase in sensitivity to FUra and both the increase in both TP mRNA levels and TP activity. Transfected cells exhibited increased formation of FdUMP, but not the ribonucleotides FUDP and FUTP, from FUra when compared to wild- type cells. The changes in TP activity, FdUMP formation, and FUra sensitivity in the transfected cells were comparable with those seen after treatment of wild-type cells with IFNα. These studies provide direct evidence for the role of TP in mediating the sensitivity of colon carcinoma cells to FUra, and further support the importance of the induction of TP in the biomodulating action of IFNα on FUra chemosensitivity.

AB - Interferon-α (IFNα) potentiates the antitumor activity of 5- fluorouracil (FUra) in colon cancer in vitro, in vivo, and clinically. A likely mechanism for this action is the induction by IFNα of thymidine phosphorylase (TP), the first enzyme in one pathway for the metabolic activation of FUra to fluorodeoxyribonucleotides. To test this hypothesis, an expression vector containing the TP cDNA was transfected into HT-29 human colon carcinoma cells. Five stable transfectants were selected and analyzed. All showed increased sensitivity to FUra cytotoxicity, ranging from a 2-fold to a 19-fold decrease in the IC50 for FUra, compared to wild-type cells. Levels of TP mRNA, protein, and enzyme activity were elevated in the transfectants, and there was a significant correlation between the relative increase in sensitivity to FUra and both the increase in both TP mRNA levels and TP activity. Transfected cells exhibited increased formation of FdUMP, but not the ribonucleotides FUDP and FUTP, from FUra when compared to wild- type cells. The changes in TP activity, FdUMP formation, and FUra sensitivity in the transfected cells were comparable with those seen after treatment of wild-type cells with IFNα. These studies provide direct evidence for the role of TP in mediating the sensitivity of colon carcinoma cells to FUra, and further support the importance of the induction of TP in the biomodulating action of IFNα on FUra chemosensitivity.

UR - http://www.scopus.com/inward/record.url?scp=0029051690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029051690&partnerID=8YFLogxK

U2 - 10.1074/jbc.270.32.19073

DO - 10.1074/jbc.270.32.19073

M3 - Article

C2 - 7642571

AN - SCOPUS:0029051690

VL - 270

SP - 19073

EP - 19077

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 32

ER -